Compounds > glycine amide
Page last updated: 2024-08-25

glycine amide and glycylprolylglycine amide

glycine amide has been researched along with glycylprolylglycine amide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersson, E; Balzarini, J; Höglund, S; Horal, P; Jejcic, A; Svennerholm, B; Vahlne, A1
Artursson, P; Hubatsch, I; Lazorova, L; Vahlne, A1
Vahlne, A; Youssefi, M1

Other Studies

3 other study(ies) available for glycine amide and glycylprolylglycine amide

ArticleYear
Glycine-amide is an active metabolite of the antiretroviral tripeptide glycyl-prolyl-glycine-amide.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:1

    Topics: Animals; Anti-HIV Agents; Cell Line; Cells, Cultured; Drug Resistance, Viral; Glycine; HIV-1; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Oligopeptides; Serial Passage; Virus Assembly; Virus Replication

2005
Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epithelium.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3

    Topics: Administration, Oral; Antiviral Agents; Biological Transport; Biotransformation; Caco-2 Cells; Dipeptidyl Peptidase 4; Glycine; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Oligopeptides

2005
Anti-human immunodeficiency virus type 1 agent alpha-hydroxy glycineamide enters the target cells via a mechanism of passive diffusion.
    The Journal of pharmacy and pharmacology, 2014, Volume: 66, Issue:10

    Topics: Anti-HIV Agents; Diffusion; Glycine; HIV-1; Humans; Kinetics; Oligopeptides; T-Lymphocytes; Temperature; Virus Replication

2014